Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity
Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity
复制标题
DOI:
10.1111/j.1600-079x.2010.00829.x
复制
发表时间:
2011-03-01
影响因子:
10.3
通讯作者:
Kim, Sung-Jo
中科院分区:
文献类型:
--
作者:
Choi, Eun-Young;Jin, Ji-Young;Kim, Sung-Jo
Although a range of biological and pharmacological activities of melatonin have been reported, little is known about its potential anti-inflammatory efficacy in periodontal disease. In this study, we investigated the effects of melatonin on the production of inflammatory mediators by murine macrophages stimulated with lipopolysaccharide (LPS) from Prevotella intermedia, a major cause of inflammatory reactions in the periodontium, and sought to determine the underlying mechanisms of action. Melatonin suppressed the production of nitric oxide (NO) and interleukin-6 (IL-6) at both gene transcription and translation levels in P. intermedia LPS-activated RAW264.7 cells. P. intermedia LPS-induced NF-kappa B-dependent luciferase activity was significantly inhibited by melatonin. Melatonin did not reduce NF-kappa B transcriptional activity at the level of I kappa B-alpha degradation. Melatonin blocked NF-kappa B signaling through the inhibition of nuclear translocation and DNA-binding activity of NF-kappa B p50 subunit and suppressed STAT1 signaling. Although further research is required to clarify the detailed mechanism of action, we conclude that melatonin may contribute to blockade of the host-destructive processes mediated by these two proinflammatory mediators and could be a highly efficient modulator of host response in the treatment of inflammatory periodontal disease.